AUERBACH ALAN H Insider Trading Activity (PBYI)

Summary

Updated Jul 16, 2026

AUERBACH ALAN H has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $531K.

Profile

Alan H. Auerbach is the President and CEO of Puma Biotechnology, Inc., a biopharmaceutical company focused on innovative cancer treatments. He has played a significant role in the development and commercialization of products aimed at improving outcomes for cancer patients.

Role	President and CEO, Director, 10% Owner
Notability	30/100

Board memberships

Puma Biotechnology, Inc.

Awards & honors

Led the commercialization of NERLYNX
Developed innovative cancer therapies
Served as a director and significant owner of Puma Biotechnology

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-09	PBYI	PUMA BIOTECHNOLOGY, INC.	S — Open-market sale	44.1K	$8.26	$364K
2026-02-21	PBYI	PUMA BIOTECHNOLOGY, INC.	A — Grant or award	159.8K	$0.00
2025-07-08	PBYI	PUMA BIOTECHNOLOGY, INC.	S — Open-market sale	21.6K	$3.54	$76K
2025-07-08	PBYI	PUMA BIOTECHNOLOGY, INC.	S — Open-market sale	25.6K	$3.53	$90K

Frequently Asked Questions

Who is AUERBACH ALAN H?

How many SEC Form 4 filings has AUERBACH ALAN H submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has AUERBACH ALAN H been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($531K) across all tracked filings.

Where can I see all of AUERBACH ALAN H's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

AUERBACH ALAN H — SEC Form 4 Insider Trading Activity